메뉴 건너뛰기




Volumn 24, Issue 5, 2013, Pages 385-392

Heart failure and anti tumor necrosis factor-alpha in systemic chronic inflammatory diseases

Author keywords

Anti tumor necrosis alpha; Chronic heart failure; Crohn's disease; Rheumatoid arthritis; Tumor necrosis factor alpha

Indexed keywords

ADALIMUMAB; CERTOLIZUMAB PEGOL; ETANERCEPT; INFLIXIMAB; METHOTREXATE; PLACEBO;

EID: 84879109580     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2012.12.015     Document Type: Review
Times cited : (73)

References (86)
  • 1
    • 35549010225 scopus 로고    scopus 로고
    • Heart failure among younger rheumatoid arthritis and Crohn's patients exposed to TNF-α antagonists
    • J.R. Curtis, J.M. Kramer, C. Martin, K.G. Saag, N. Patkar, and G. Satin Heart failure among younger rheumatoid arthritis and Crohn's patients exposed to TNF-α antagonists Rheumatology 46 2007 1688 1693
    • (2007) Rheumatology , vol.46 , pp. 1688-1693
    • Curtis, J.R.1    Kramer, J.M.2    Martin, C.3    Saag, K.G.4    Patkar, N.5    Satin, G.6
  • 2
    • 34547742119 scopus 로고    scopus 로고
    • Cardiac involvement in systemic inflammatory diseases
    • D.C. Knockaert Cardiac involvement in systemic inflammatory diseases Eur Heart J 28 2007 1797 1804
    • (2007) Eur Heart J , vol.28 , pp. 1797-1804
    • Knockaert, D.C.1
  • 3
    • 0034754477 scopus 로고    scopus 로고
    • Etanercept for active Crohn's disease: A randomized, double-blind, placebo-controlled trial
    • W.J. Sandborn, S.B. Hanauer, S. Katz, M. Safdi, D.G. Wolf, and R.D. Baerg Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial Gastroenterology 121 2001 1088 1094
    • (2001) Gastroenterology , vol.121 , pp. 1088-1094
    • Sandborn, W.J.1    Hanauer, S.B.2    Katz, S.3    Safdi, M.4    Wolf, D.G.5    Baerg, R.D.6
  • 4
    • 1842632413 scopus 로고    scopus 로고
    • Anti-tumor necrosis factor alpha therapy and heart failure - What have we learned and where do we go from here?
    • D. Khanna, M. McMahon, and D.E. Furst Anti-tumor necrosis factor alpha therapy and heart failure - what have we learned and where do we go from here? Arthritis Rheum 4 2004 1040 1050
    • (2004) Arthritis Rheum , vol.4 , pp. 1040-1050
    • Khanna, D.1    McMahon, M.2    Furst, D.E.3
  • 5
    • 0037195727 scopus 로고    scopus 로고
    • Inflammatory mediators and the failing heart: Past, present, and the foreseeable future
    • D.L. Mann Inflammatory mediators and the failing heart: past, present, and the foreseeable future Circ Res 91 2002 988 998
    • (2002) Circ Res , vol.91 , pp. 988-998
    • Mann, D.L.1
  • 6
    • 1642463859 scopus 로고    scopus 로고
    • Inflammatory mediators in chronic heart failure: An overview
    • S.D. Anker, and S. von Haehling Inflammatory mediators in chronic heart failure: an overview Heart 90 2004 464 470
    • (2004) Heart , vol.90 , pp. 464-470
    • Anker, S.D.1    Von Haehling, S.2
  • 7
    • 0025286817 scopus 로고
    • Elevated circulating levels of tumor necrosis factor in severe chronic heart failure
    • B. Levine, J. Kalman, L. Mayer, H.M. Fillit, and M. Packer Elevated circulating levels of tumor necrosis factor in severe chronic heart failure N Engl J Med 323 1990 236 241
    • (1990) N Engl J Med , vol.323 , pp. 236-241
    • Levine, B.1    Kalman, J.2    Mayer, L.3    Fillit, H.M.4    Packer, M.5
  • 8
    • 0027483722 scopus 로고
    • Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart
    • T. Yokoyama, L. Vaca, R.D. Rossen, W. Durante, P. Hazarika, and D.L. Mann Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart J Clin Invest 92 1993 2303 2312
    • (1993) J Clin Invest , vol.92 , pp. 2303-2312
    • Yokoyama, T.1    Vaca, L.2    Rossen, R.D.3    Durante, W.4    Hazarika, P.5    Mann, D.L.6
  • 9
    • 0032515950 scopus 로고    scopus 로고
    • Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats
    • B. Bozkurt, S.B. Kribbs, F.J. Clubb Jr., L.H. Michael, V.V. Didenko, and P.J. Hornsby Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats Circulation 97 1998 1382 1391
    • (1998) Circulation , vol.97 , pp. 1382-1391
    • Bozkurt, B.1    Kribbs, S.B.2    Clubb, Jr.F.J.3    Michael, L.H.4    Didenko, V.V.5    Hornsby, P.J.6
  • 10
    • 0026779727 scopus 로고
    • Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-alpha in conscious dogs
    • F.D. Pagani, L.S. Baker, C. Hsi, M. Knox, M.P. Fink, and M.S. Visner Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-alpha in conscious dogs J Clin Invest 90 1992 389 398
    • (1992) J Clin Invest , vol.90 , pp. 389-398
    • Pagani, F.D.1    Baker, L.S.2    Hsi, C.3    Knox, M.4    Fink, M.P.5    Visner, M.S.6
  • 11
    • 58149130150 scopus 로고    scopus 로고
    • Immune modulation: Role of the inflammatory cytokine cascade in the failing human heart
    • M. Satoh, Y. Minami, Y. Takahashi, and M. Nakamura Immune modulation: role of the inflammatory cytokine cascade in the failing human heart Curr Heart Fail Rep 5 2008 69 74
    • (2008) Curr Heart Fail Rep , vol.5 , pp. 69-74
    • Satoh, M.1    Minami, Y.2    Takahashi, Y.3    Nakamura, M.4
  • 12
    • 0343875590 scopus 로고
    • Interleukin 1 and tumor necrosis factor inhibit myocyte b-adrenergic responsiveness
    • T. Gulick, M.K. Chung, S.J. Pieper, L.G. Lange, and G.F. Schreiner Interleukin 1 and tumor necrosis factor inhibit myocyte b-adrenergic responsiveness Proc Natl Acad Sci 86 1989 6753 6757
    • (1989) Proc Natl Acad Sci , vol.86 , pp. 6753-6757
    • Gulick, T.1    Chung, M.K.2    Pieper, S.J.3    Lange, L.G.4    Schreiner, G.F.5
  • 13
    • 4744348381 scopus 로고    scopus 로고
    • In vivo TNF-A inhibition ameliorates cardiac mitochondrial dysfunction, oxidative stress, and apoptosis in experimental heart failure
    • G.W. Moe, J. Marin-Garcia, A. Konig, M. Goldenthal, X. Lu, and Q. Feng In vivo TNF-a inhibition ameliorates cardiac mitochondrial dysfunction, oxidative stress, and apoptosis in experimental heart failure Am J Physiol Heart Circ Physiol 287 2004 H1813 H1820
    • (2004) Am J Physiol Heart Circ Physiol , vol.287
    • Moe, G.W.1    Marin-Garcia, J.2    Konig, A.3    Goldenthal, M.4    Lu, X.5    Feng, Q.6
  • 14
    • 0029975877 scopus 로고    scopus 로고
    • Tumor necrosis factor a and interleukin 1b are responsible for in vitro myocardial cell depression induced by human septic shock serum
    • A. Kumar, V. Thota, L. Dee, J. Olson, E. Uretz, and J.E. Parrillo Tumor necrosis factor a and interleukin 1b are responsible for in vitro myocardial cell depression induced by human septic shock serum J Exp Med 183 1996 949 958
    • (1996) J Exp Med , vol.183 , pp. 949-958
    • Kumar, A.1    Thota, V.2    Dee, L.3    Olson, J.4    Uretz, E.5    Parrillo, J.E.6
  • 17
    • 78650971588 scopus 로고    scopus 로고
    • TNF alpha in myocardial ischemia/reperfusion, remodeling and heart failure
    • P. Kleinbogard, R. Schulz, and G. Heusch TNF alpha in myocardial ischemia/reperfusion, remodeling and heart failure Heart Fail Rev 16 2011 49 69
    • (2011) Heart Fail Rev , vol.16 , pp. 49-69
    • Kleinbogard, P.1    Schulz, R.2    Heusch, G.3
  • 18
    • 0037022910 scopus 로고    scopus 로고
    • Inflammation and atherosclerosis
    • P. Libby, P.M. Ridker, and A. Maseri Inflammation and atherosclerosis Circulation 105 2002 1135 1143
    • (2002) Circulation , vol.105 , pp. 1135-1143
    • Libby, P.1    Ridker, P.M.2    Maseri, A.3
  • 19
    • 20044381106 scopus 로고    scopus 로고
    • Tumor necrosis factor-A receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction. The cytokine-activation and long-term prognosis in myocardial infarction (C-ALPHA) study
    • M. Valgimigli, C. Ceconi, P. Malagutti, E. Merli, O. Soukhomovskaia, and G. Francolini Tumor necrosis factor-a receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction. The cytokine-activation and long-term prognosis in myocardial infarction (C-ALPHA) study Circulation 111 2005 863 870
    • (2005) Circulation , vol.111 , pp. 863-870
    • Valgimigli, M.1    Ceconi, C.2    Malagutti, P.3    Merli, E.4    Soukhomovskaia, O.5    Francolini, G.6
  • 20
    • 54549110222 scopus 로고    scopus 로고
    • Common community infections and the risk for coronary artery disease and acute myocardial infarction: Evidence for chronic over-expression of tumor necrosis factor alpha and vascular cells adhesion molecule-1
    • A. Nikolopoulou, D. Tousoulis, C. Antoniades, K. Petroheilou, C. Vasiliadou, and N. Papageorgiou Common community infections and the risk for coronary artery disease and acute myocardial infarction: evidence for chronic over-expression of tumor necrosis factor alpha and vascular cells adhesion molecule-1 Int J Cardiol 130 2008 246 250
    • (2008) Int J Cardiol , vol.130 , pp. 246-250
    • Nikolopoulou, A.1    Tousoulis, D.2    Antoniades, C.3    Petroheilou, K.4    Vasiliadou, C.5    Papageorgiou, N.6
  • 21
    • 33645538914 scopus 로고    scopus 로고
    • C-reactive protein, interleukin-6 and tumor necrosis factor alpha as predictors of incident coronary and cardiovascular events and total mortality. A population-based, prospective study
    • K. Tuomisto, P. Jousilahti, J. Sundvall, P. Pajunen, and V. Salomaa C-reactive protein, interleukin-6 and tumor necrosis factor alpha as predictors of incident coronary and cardiovascular events and total mortality. A population-based, prospective study Thromb Haemost 95 2006 511 518
    • (2006) Thromb Haemost , vol.95 , pp. 511-518
    • Tuomisto, K.1    Jousilahti, P.2    Sundvall, J.3    Pajunen, P.4    Salomaa, V.5
  • 22
    • 70749088135 scopus 로고    scopus 로고
    • Elevated plasma levels of TNF-alpha and interleukin-6 in patients with diastolic dysfunction and glucose metabolism disorders
    • W. Dinh, R. Futh, W. Nickl, T. Krahn, P. Ellinghaus, and T. Scheffold Elevated plasma levels of TNF-alpha and interleukin-6 in patients with diastolic dysfunction and glucose metabolism disorders Cardiovasc Diabetol 8 2009 58
    • (2009) Cardiovasc Diabetol , vol.8 , pp. 58
    • Dinh, W.1    Futh, R.2    Nickl, W.3    Krahn, T.4    Ellinghaus, P.5    Scheffold, T.6
  • 23
    • 70350074632 scopus 로고    scopus 로고
    • Plasma concentrations of TNF-A and its soluble receptors sTNFR1 and sTNFR2 in patients with coronary artery disease
    • K. Safranow, V. Dziedziejko, R. Rzeuski, E. Czyzycka, A. Wojtarowicz, and A. Binczak-Kuleta Plasma concentrations of TNF-a and its soluble receptors sTNFR1 and sTNFR2 in patients with coronary artery disease Tissue Antigens 74 2009 386 392
    • (2009) Tissue Antigens , vol.74 , pp. 386-392
    • Safranow, K.1    Dziedziejko, V.2    Rzeuski, R.3    Czyzycka, E.4    Wojtarowicz, A.5    Binczak-Kuleta, A.6
  • 24
    • 0037465808 scopus 로고    scopus 로고
    • Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction
    • R.S. Vasan, L.M. Sullivan, R. Roubenoff, C.A. Dinarello, T. Harris, and E.J. Benjamin Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction Circulation 107 2003 1486 1491
    • (2003) Circulation , vol.107 , pp. 1486-1491
    • Vasan, R.S.1    Sullivan, L.M.2    Roubenoff, R.3    Dinarello, C.A.4    Harris, T.5    Benjamin, E.J.6
  • 25
    • 77950506582 scopus 로고    scopus 로고
    • Inflammatory cytokines in heart failure: Roles in aetiology and utility as biomarkers
    • L. Tamariz, and J.M. Hare Inflammatory cytokines in heart failure: roles in aetiology and utility as biomarkers Eur Heart J 31 2010 768 770
    • (2010) Eur Heart J , vol.31 , pp. 768-770
    • Tamariz, L.1    Hare, J.M.2
  • 26
    • 0035942264 scopus 로고    scopus 로고
    • Cytokines and cytokine receptors in advanced heart failure. An analysis of the cytokine database from the vesnarinone trial (VEST)
    • A. Deswal, N.J. Petersen, A.M. Feldman, J.B. Young, B.G. White, and D.L. Mann Cytokines and cytokine receptors in advanced heart failure. An analysis of the cytokine database from the vesnarinone trial (VEST) Circulation 103 2001 2055 2059
    • (2001) Circulation , vol.103 , pp. 2055-2059
    • Deswal, A.1    Petersen, N.J.2    Feldman, A.M.3    Young, J.B.4    White, B.G.5    Mann, D.L.6
  • 27
    • 0029117828 scopus 로고
    • Tumor necrosis factor solubile receptors in patients with various degrees of congestive heart failure
    • R. Ferrari, T. Bachetti, R. Confortini, C. Opasich, O. Febo, and A. Corti Tumor necrosis factor solubile receptors in patients with various degrees of congestive heart failure Circulation 92 1995 1479 1486
    • (1995) Circulation , vol.92 , pp. 1479-1486
    • Ferrari, R.1    Bachetti, T.2    Confortini, R.3    Opasich, C.4    Febo, O.5    Corti, A.6
  • 28
    • 0034687595 scopus 로고    scopus 로고
    • Plasma cytokine parameters and mortality in patients with chronic heart failure
    • M. Rauchhaus, W. Doehner, D.P. Francis, C. Davos, M. Kemp, and C. Liebenthal Plasma cytokine parameters and mortality in patients with chronic heart failure Circulation 102 2000 3060 3067
    • (2000) Circulation , vol.102 , pp. 3060-3067
    • Rauchhaus, M.1    Doehner, W.2    Francis, D.P.3    Davos, C.4    Kemp, M.5    Liebenthal, C.6
  • 29
    • 77954242107 scopus 로고    scopus 로고
    • TNFα in atherosclerosis, myocardial ischemia/reperfusion and heart failure
    • P. Kleinbogard, R. Schulz, and G. Heusch TNFα in atherosclerosis, myocardial ischemia/reperfusion and heart failure Pharmacol Ther 127 2010 295 314
    • (2010) Pharmacol Ther , vol.127 , pp. 295-314
    • Kleinbogard, P.1    Schulz, R.2    Heusch, G.3
  • 30
    • 0033614816 scopus 로고    scopus 로고
    • Safety and efficacy of a soluble p75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure
    • A. Deswal, B. Bozkurt, Y. Seta, F. Parilti-Eiswirth, F. Ann Hayes, and D.L. Mann Safety and efficacy of a soluble p75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure Circulation 99 1999 3224 3226
    • (1999) Circulation , vol.99 , pp. 3224-3226
    • Deswal, A.1    Bozkurt, B.2    Seta, Y.3    Parilti-Eiswirth, F.4    Ann Hayes, F.5    Mann, D.L.6
  • 31
    • 0035957036 scopus 로고    scopus 로고
    • Results of targeted antitumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure
    • B. Bozkurt, G. Torre-Amione, M.S. Warren, J. Whitmore, O.Z. Soren, and A.M. Feldman Results of targeted antitumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure Circulation 103 2001 1044 1047
    • (2001) Circulation , vol.103 , pp. 1044-1047
    • Bozkurt, B.1    Torre-Amione, G.2    Warren, M.S.3    Whitmore, J.4    Soren, O.Z.5    Feldman, A.M.6
  • 32
    • 0036888364 scopus 로고    scopus 로고
    • How to RECOVER from RENAISSANCE? the significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH
    • S.D. Anker, and A.J. Coats How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH Int J Cardiol 86 2002 123 130
    • (2002) Int J Cardiol , vol.86 , pp. 123-130
    • Anker, S.D.1    Coats, A.J.2
  • 34
    • 11144355760 scopus 로고    scopus 로고
    • Targeted anticytokine therapy in patients with chronic heart failure. Results of the randomized etanercept worldwide evaluation (RENEWAL)
    • D.L. Mann, J.J.V. McMurray, M. Packer, K. Swedberg, J.S. Borer, and W.S. Colucci Targeted anticytokine therapy in patients with chronic heart failure. Results of the randomized etanercept worldwide evaluation (RENEWAL) Circulation 109 2004 1594 1602
    • (2004) Circulation , vol.109 , pp. 1594-1602
    • Mann, D.L.1    McMurray, J.J.V.2    Packer, M.3    Swedberg, K.4    Borer, J.S.5    Colucci, W.S.6
  • 36
    • 0038755661 scopus 로고    scopus 로고
    • Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-A, in patients with moderate-to-severe heart failure
    • E.S. Chung, M. Packer, K.H. Lo, A.A. Fasanmade, and J.T. Willerson Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-a, in patients with moderate-to-severe heart failure Circulation 107 2003 3133 3140
    • (2003) Circulation , vol.107 , pp. 3133-3140
    • Chung, E.S.1    Packer, M.2    Lo, K.H.3    Fasanmade, A.A.4    Willerson, J.T.5
  • 37
    • 0011168402 scopus 로고    scopus 로고
    • Effects of cytokine antagonism with etanercept on morbidity and mortality in chronic heart failure:results of the randomized etanercept world-wide evaluation (RENEWAL) trial
    • J. McMurray, and D.L. Mann Effects of cytokine antagonism with etanercept on morbidity and mortality in chronic heart failure:results of the randomized etanercept world-wide evaluation (RENEWAL) trial Heart Failure 2002 Meeting. Hot Line Session. Oral presentation, Oslo/Norway,10th June, 2002 2002
    • (2002) Heart Failure 2002 Meeting. Hot Line Session. Oral Presentation, Oslo/Norway,10th June, 2002
    • McMurray, J.1    Mann, D.L.2
  • 38
    • 84894883299 scopus 로고    scopus 로고
    • A phase II, multicenter, randomized, double-blind, placebo-controlled pilot trial evaluating the effects of infliximab (Remicade) in patients with stable class III or IV congestive heart failure ("ATTACH")
    • M. Packer A phase II, multicenter, randomized, double-blind, placebo-controlled pilot trial evaluating the effects of infliximab (Remicade) in patients with stable class III or IV congestive heart failure ("ATTACH") Heart Failure 2002 Meeting. Hot Line Session. Oral presentation, Oslo/Norway, 10th June, 2002 2002
    • (2002) Heart Failure 2002 Meeting. Hot Line Session. Oral Presentation, Oslo/Norway, 10th June, 2002
    • Packer, M.1
  • 39
    • 78649912194 scopus 로고    scopus 로고
    • The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factor-alpha antagonist therapy in Inflammatory Bowel Disease
    • A. Orlando, A. Armuzzi, C. Papi, V. Annese, S. Ardizzone, and L. Biancone The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: the use of tumor necrosis factor-alpha antagonist therapy in Inflammatory Bowel Disease Dig Liver Dis 43 2011 1 20
    • (2011) Dig Liver Dis , vol.43 , pp. 1-20
    • Orlando, A.1    Armuzzi, A.2    Papi, C.3    Annese, V.4    Ardizzone, S.5    Biancone, L.6
  • 41
    • 0036229685 scopus 로고    scopus 로고
    • Accelerated atherosclerosis: An extraarticular feature of rheumatoid arthritis?
    • S. Van Doornum, G. McColl, and I.P. Wicks Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis? Arthritis Rheum 46 2002 862 873
    • (2002) Arthritis Rheum , vol.46 , pp. 862-873
    • Van Doornum, S.1    McColl, G.2    Wicks, I.P.3
  • 42
    • 77956925678 scopus 로고    scopus 로고
    • The effect of pharmacological therapy on the cardiovascular system of patients with systemic rheumatic diseases
    • F. Atzeni, M. Turiel, and R. Caporali The effect of pharmacological therapy on the cardiovascular system of patients with systemic rheumatic diseases Autoimmun Rev 9 2010 835 839
    • (2010) Autoimmun Rev , vol.9 , pp. 835-839
    • Atzeni, F.1    Turiel, M.2    Caporali, R.3
  • 43
    • 0035676529 scopus 로고    scopus 로고
    • High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors
    • I. Del Rincon, K. Williams, M.P. Stern, G.L. Freeman, and A. Escalante High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors Arthritis Rheum 44 2001 2737 2745
    • (2001) Arthritis Rheum , vol.44 , pp. 2737-2745
    • Del Rincon, I.1    Williams, K.2    Stern, M.P.3    Freeman, G.L.4    Escalante, A.5
  • 45
    • 0037643388 scopus 로고    scopus 로고
    • All-cause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis, or no arthritis in the UK General Practice Research Database
    • D.J. Watson, T. Rhodes, and H.A. Guess All-cause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis, or no arthritis in the UK General Practice Research Database J Rheumatol 30 2003 1196 1202
    • (2003) J Rheumatol , vol.30 , pp. 1196-1202
    • Watson, D.J.1    Rhodes, T.2    Guess, H.A.3
  • 46
    • 28544447858 scopus 로고    scopus 로고
    • Disease modification and cardiovascular risk reduction: Two sides of the same coin?
    • F.C. Hall, and N. Dalbeth Disease modification and cardiovascular risk reduction: two sides of the same coin? Rheumatology 44 2005 1473 1482
    • (2005) Rheumatology , vol.44 , pp. 1473-1482
    • Hall, F.C.1    Dalbeth, N.2
  • 47
    • 1242315583 scopus 로고    scopus 로고
    • Heart failure in rheumatoid arthritis: Rates, predictors, and the effect of anti-tumor necrosis factor therapy
    • F. Wolfe, and K. Michaud Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti-tumor necrosis factor therapy Am J Med 116 2004 305 311
    • (2004) Am J Med , vol.116 , pp. 305-311
    • Wolfe, F.1    Michaud, K.2
  • 48
    • 40549134937 scopus 로고    scopus 로고
    • Does tumor necrosis factor alpha inhibition promote or prevent heart failure in patients with rheumatoid arthritis?
    • J. Listing, A. Strangfeld, J. Kekow, M. Schneider, A. Kapelle, and S. Wassenberg Does tumor necrosis factor alpha inhibition promote or prevent heart failure in patients with rheumatoid arthritis? Arthritis Rheum 58 2008 667 677
    • (2008) Arthritis Rheum , vol.58 , pp. 667-677
    • Listing, J.1    Strangfeld, A.2    Kekow, J.3    Schneider, M.4    Kapelle, A.5    Wassenberg, S.6
  • 49
    • 22244443784 scopus 로고    scopus 로고
    • Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis
    • L.T. Jacobsson, C. Turesson, A. Gülfe, M.C. Kapetanovic, I.F. Petersson, and T. Saxne Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis J Rheumatol 32 2005 1213 1218
    • (2005) J Rheumatol , vol.32 , pp. 1213-1218
    • Jacobsson, L.T.1    Turesson, C.2    Gülfe, A.3    Kapetanovic, M.C.4    Petersson, I.F.5    Saxne, T.6
  • 50
    • 34848898513 scopus 로고    scopus 로고
    • Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: Results from the British Society for Rheumatology Biologics Register
    • W.G. Dixon, K.D. Watson, M. Lunt, K.L. Hyrich, British Society for Rheumatology Biologics Register Control Centre Consortium, and A.J. Silman Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register Arthritis Rheum 56 2007 2905 2912
    • (2007) Arthritis Rheum , vol.56 , pp. 2905-2912
    • Dixon, W.G.1    Watson, K.D.2    Lunt, M.3    Hyrich, K.L.4
  • 51
    • 16844372053 scopus 로고    scopus 로고
    • TNF-alpha, rheumatoid arthritis, and heart failure: A rheumatological dilemma
    • P. Sarzi-Puttini, F. Atzeni, Y. Shoenfeld, and G. Ferraccioli TNF-alpha, rheumatoid arthritis, and heart failure: a rheumatological dilemma Autoimmun Rev 4 2005 153 161
    • (2005) Autoimmun Rev , vol.4 , pp. 153-161
    • Sarzi-Puttini, P.1    Atzeni, F.2    Shoenfeld, Y.3    Ferraccioli, G.4
  • 52
    • 4243874480 scopus 로고
    • Association of ulcerative colitis and ischemic heart disease
    • H. Nuutinen, M. Reunanen, and M. Farrkkila Association of ulcerative colitis and ischemic heart disease Gastroenterology 108A 1995 886
    • (1995) Gastroenterology , vol.108 A , pp. 886
    • Nuutinen, H.1    Reunanen, M.2    Farrkkila, M.3
  • 53
    • 0004545156 scopus 로고    scopus 로고
    • Association of Crohn's disease and ischemic heart disease
    • H. Nuutinen, M. Reunanen, and M. Farrkkila Association of Crohn's disease and ischemic heart disease Gastroenterology 110A 1996 981
    • (1996) Gastroenterology , vol.110 A , pp. 981
    • Nuutinen, H.1    Reunanen, M.2    Farrkkila, M.3
  • 54
    • 66949138571 scopus 로고    scopus 로고
    • Risk of arterial thrombotic events in inflammatory bowel disease
    • C. Ha, S. Magowan, N.A. Accort, J. Chen, and C.D. Stone Risk of arterial thrombotic events in inflammatory bowel disease Am J Gastroenterol 104 2009 1445 1451
    • (2009) Am J Gastroenterol , vol.104 , pp. 1445-1451
    • Ha, C.1    Magowan, S.2    Accort, N.A.3    Chen, J.4    Stone, C.D.5
  • 57
    • 27744546460 scopus 로고    scopus 로고
    • Thrombosis in inflammatory bowel disease: Role of inherited thrombophilia
    • L. Spina, S. Saibeni, and T. Battaglioli Thrombosis in inflammatory bowel disease: role of inherited thrombophilia Am J Gastroenterol 100 2005 2036 2041
    • (2005) Am J Gastroenterol , vol.100 , pp. 2036-2041
    • Spina, L.1    Saibeni, S.2    Battaglioli, T.3
  • 58
    • 25444497459 scopus 로고    scopus 로고
    • Systemic thromboembolism in inflammatory bowel disease: Mechanisms and clinical applications
    • G. Twig, G. Zandman-Goddard, and M. Szyper-Kravitz Systemic thromboembolism in inflammatory bowel disease: mechanisms and clinical applications Ann N Y Acad Sci 1051 2005 166 173
    • (2005) Ann N y Acad Sci , vol.1051 , pp. 166-173
    • Twig, G.1    Zandman-Goddard, G.2    Szyper-Kravitz, M.3
  • 59
    • 0141609935 scopus 로고    scopus 로고
    • Inflammation and thrombosis
    • C.T. Esmon Inflammation and thrombosis J Thromb Haemost 1 2003 1343 1348
    • (2003) J Thromb Haemost , vol.1 , pp. 1343-1348
    • Esmon, C.T.1
  • 60
    • 33846542418 scopus 로고    scopus 로고
    • Mutations in clotting factors and inflammatory bowel disease
    • C.N. Bernstein, M. Sargent, and H.L. Vos Mutations in clotting factors and inflammatory bowel disease Am J Gastroenterol 102 2007 338 343
    • (2007) Am J Gastroenterol , vol.102 , pp. 338-343
    • Bernstein, C.N.1    Sargent, M.2    Vos, H.L.3
  • 61
    • 0030895756 scopus 로고    scopus 로고
    • Thrombosis in inflamatory bowel disease: Clinical setting, procoagulant proB le and Factor v Leiden
    • L.M. Jackson, P.J. O'Gorman, J. O'Connell, C.C. Cronin, K.P. Cotter, and F. Shanahan Thrombosis in inflamatory bowel disease: clinical setting, procoagulant proB le and Factor V Leiden Q J Med 90 1997 183 188
    • (1997) Q J Med , vol.90 , pp. 183-188
    • Jackson, L.M.1    O'Gorman, P.J.2    O'Connell, J.3    Cronin, C.C.4    Cotter, K.P.5    Shanahan, F.6
  • 65
    • 15944369567 scopus 로고    scopus 로고
    • The vasculature and inflammatory bowel disease: Contribution to pathogenesis and clinical pathology
    • O.A. Hatoum, and D.G. Binion The vasculature and inflammatory bowel disease: contribution to pathogenesis and clinical pathology Inflamm Bowel Dis 11 2005 304 313
    • (2005) Inflamm Bowel Dis , vol.11 , pp. 304-313
    • Hatoum, O.A.1    Binion, D.G.2
  • 66
    • 0142200971 scopus 로고    scopus 로고
    • The vascular contribution in the pathogenesis of inflammatory bowel disease
    • O.A. Hatoum, H. Miura, and D.G. Binion The vascular contribution in the pathogenesis of inflammatory bowel disease Am J Physiol Heart Circ Physiol 285 2003 H1791 H1796
    • (2003) Am J Physiol Heart Circ Physiol , vol.285
    • Hatoum, O.A.1    Miura, H.2    Binion, D.G.3
  • 67
    • 0031444861 scopus 로고    scopus 로고
    • Platelet aggregation and neutrophil sequestration in the mesenteric circulation in inflammatory bowel disease
    • C.E. Collins, D.S. Rampton, J. Rogers, and N.S. Williams Platelet aggregation and neutrophil sequestration in the mesenteric circulation in inflammatory bowel disease Eur J Gastroenterol Hepatol 9 1997 1213 1217
    • (1997) Eur J Gastroenterol Hepatol , vol.9 , pp. 1213-1217
    • Collins, C.E.1    Rampton, D.S.2    Rogers, J.3    Williams, N.S.4
  • 68
    • 0033552883 scopus 로고    scopus 로고
    • Atherosclerosis - An inflammatory disease
    • R. Ross Atherosclerosis - an inflammatory disease N Engl J Med 340 1999 115 126
    • (1999) N Engl J Med , vol.340 , pp. 115-126
    • Ross, R.1
  • 69
    • 17644412023 scopus 로고    scopus 로고
    • Inflammation, atherosclerosis and coronary artery disease
    • G.K. Hannson Inflammation, atherosclerosis and coronary artery disease N Engl J Med 352 2005 1685 1695
    • (2005) N Engl J Med , vol.352 , pp. 1685-1695
    • Hannson, G.K.1
  • 70
    • 21844451117 scopus 로고    scopus 로고
    • C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: The Cardiovascular Health Study
    • M. Cushman, A.M. Arnold, B.M. Psaty, T.A. Manolio, L.H. Kuller, and G.L. Burke C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the Cardiovascular Health Study Circulation 112 2005 25 31
    • (2005) Circulation , vol.112 , pp. 25-31
    • Cushman, M.1    Arnold, A.M.2    Psaty, B.M.3    Manolio, T.A.4    Kuller, L.H.5    Burke, G.L.6
  • 71
    • 23944476094 scopus 로고    scopus 로고
    • Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer
    • R. Atreya, and M.F. Neurath Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer Clin Rev Allergy Immunol 28 2005 187 196
    • (2005) Clin Rev Allergy Immunol , vol.28 , pp. 187-196
    • Atreya, R.1    Neurath, M.F.2
  • 72
    • 0037190065 scopus 로고    scopus 로고
    • Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: Prospective analysis from the women's health initiative observational study
    • A.D. Pradhan, J.E. Manson, J.E. Rossouw, D.S. Siscovick, C.P. Mouton, and N. Rifai Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the women's health initiative observational study JAMA 288 2002 980 987
    • (2002) JAMA , vol.288 , pp. 980-987
    • Pradhan, A.D.1    Manson, J.E.2    Rossouw, J.E.3    Siscovick, D.S.4    Mouton, C.P.5    Rifai, N.6
  • 74
    • 0037672879 scopus 로고    scopus 로고
    • Case reports of heart failure after therapy with a tumor necrosis factor antagonist
    • H.J. Kwon, T.R. Cote, M.S. Cuffe, J.M. Kramer, and M.M. Braun Case reports of heart failure after therapy with a tumor necrosis factor antagonist Ann Intern Med 138 2003 807 811
    • (2003) Ann Intern Med , vol.138 , pp. 807-811
    • Kwon, H.J.1    Cote, T.R.2    Cuffe, M.S.3    Kramer, J.M.4    Braun, M.M.5
  • 75
    • 4944223125 scopus 로고    scopus 로고
    • Unusual toxicities with TNF inhibition: Heart failure and drug-induced lupus
    • J.J. Cush Unusual toxicities with TNF inhibition: heart failure and drug-induced lupus Clin Exp Rheumatol 22 2004 S141 S147
    • (2004) Clin Exp Rheumatol , vol.22
    • Cush, J.J.1
  • 76
    • 33745064418 scopus 로고    scopus 로고
    • Safety analyses of adalimumab (HUMIRA) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis
    • M.H. Schiff, G.R. Burmester, J.D. Kent, A.L. Pangan, H. Kupper, and S.B. Fitzpatrick Safety analyses of adalimumab (HUMIRA) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis Ann Rheum Dis 65 2006 889 894
    • (2006) Ann Rheum Dis , vol.65 , pp. 889-894
    • Schiff, M.H.1    Burmester, G.R.2    Kent, J.D.3    Pangan, A.L.4    Kupper, H.5    Fitzpatrick, S.B.6
  • 77
    • 19944433874 scopus 로고    scopus 로고
    • Results from a nationwide postmarketing cohort study of patients in Sweden treated with etanercept
    • N. Feltelius, C.M. Fored, P. Blomqvist, L. Bertilsson, P. Geborek, and L.T. Jacobsson Results from a nationwide postmarketing cohort study of patients in Sweden treated with etanercept Ann Rheum Dis 64 2005 246 252
    • (2005) Ann Rheum Dis , vol.64 , pp. 246-252
    • Feltelius, N.1    Fored, C.M.2    Blomqvist, P.3    Bertilsson, L.4    Geborek, P.5    Jacobsson, L.T.6
  • 78
    • 33846278750 scopus 로고    scopus 로고
    • The incidence of new onset congestive heart failure and heart failure exacerbation in Veteran's Affairs patients receiving tumor necrosis factor alpha antagonists
    • J. Cole, A. Busti, and S. Kazi The incidence of new onset congestive heart failure and heart failure exacerbation in Veteran's Affairs patients receiving tumor necrosis factor alpha antagonists Rheumatol Int 27 2007 369 373
    • (2007) Rheumatol Int , vol.27 , pp. 369-373
    • Cole, J.1    Busti, A.2    Kazi, S.3
  • 79
    • 21244436822 scopus 로고    scopus 로고
    • Antirheumatic drug use and risk of hospitalization for congestive heart failure in rheumatoid arthritis
    • S. Bernatsky, M. Hudson, and S. Suissa Antirheumatic drug use and risk of hospitalization for congestive heart failure in rheumatoid arthritis Rheumatology 44 2005 677 680
    • (2005) Rheumatology , vol.44 , pp. 677-680
    • Bernatsky, S.1    Hudson, M.2    Suissa, S.3
  • 80
    • 35549010225 scopus 로고    scopus 로고
    • Heart failure among younger rheumatoid arthritis and Crohn's patients exposed to TNF-alpha antagonists
    • J.R. Curtis, J.M. Kramer, C. Martin, K.g. Saag, N. Patkar, and D. Shatin Heart failure among younger rheumatoid arthritis and Crohn's patients exposed to TNF-alpha antagonists Rheumatology 46 2007 1688 1693
    • (2007) Rheumatology , vol.46 , pp. 1688-1693
    • Curtis, J.R.1    Kramer, J.M.2    Martin, C.3    Saag, K.G.4    Patkar, N.5    Shatin, D.6
  • 81
    • 34347251548 scopus 로고    scopus 로고
    • All-cause and causespecific mortality in rheumatoid arthritis are not greater than expected when treated with tumour necrosis factor antagonists
    • L. Carmona, M.A. Descalzo, E. Perez-Pampin, D. Ruiz-Montesinos, A. Erra, and T. Cobo All-cause and causespecific mortality in rheumatoid arthritis are not greater than expected when treated with tumour necrosis factor antagonists Ann Rheum Dis 66 2007 880 885
    • (2007) Ann Rheum Dis , vol.66 , pp. 880-885
    • Carmona, L.1    Descalzo, M.A.2    Perez-Pampin, E.3    Ruiz-Montesinos, D.4    Erra, A.5    Cobo, T.6
  • 82
    • 79957461056 scopus 로고    scopus 로고
    • Systematic review and meta-analysis: Anti-tumor necrosis factor alpha therapy and cardiovascular events in rheumatoid arthritis
    • C. Barnabe, B.J. Martin, and W.A. Ghali Systematic review and meta-analysis: anti-tumor necrosis factor alpha therapy and cardiovascular events in rheumatoid arthritis Arthritis Care Res 63 2011 522 529
    • (2011) Arthritis Care Res , vol.63 , pp. 522-529
    • Barnabe, C.1    Martin, B.J.2    Ghali, W.A.3
  • 85
    • 18744380397 scopus 로고    scopus 로고
    • A 49-year-old male with acute superior mesenteric artery occlusion during active ulcerative colitis: Report of a case
    • R.S. Brown, S. Armen, A. Patmanaban, T.H. Hartranft, and P.D. Price A 49-year-old male with acute superior mesenteric artery occlusion during active ulcerative colitis: report of a case Dis Colon Rectum 48 2005 572 574
    • (2005) Dis Colon Rectum , vol.48 , pp. 572-574
    • Brown, R.S.1    Armen, S.2    Patmanaban, A.3    Hartranft, T.H.4    Price, P.D.5
  • 86
    • 33847253913 scopus 로고    scopus 로고
    • Inflammatory Bowel disease is not a risk factor for cardiovascular disease mortality: Results from a systematic review and metaanalysis
    • S.P. Dorn, and R.S. Sandler Inflammatory Bowel disease is not a risk factor for cardiovascular disease mortality: results from a systematic review and metaanalysis Am J Gastroenterol 102 2007 662 667
    • (2007) Am J Gastroenterol , vol.102 , pp. 662-667
    • Dorn, S.P.1    Sandler, R.S.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.